Articles from Thalia Therapeutics PLC

Thalia Therapeutics PLC Announces Acquisition and £2.75 Million Fundraise
Acquisition of oncology company Sanmirna Therapeutics Inc for its clinical-stage Acute Myeloid Leukaemia RNA therapy
By Thalia Therapeutics PLC · Via ACCESS Newswire · June 24, 2026
Articles from Thalia Therapeutics PLC | MarketMinute